Tapewire

Nasdaq · USD

AMGN

AMGEN INC

Export transactions ↓
Tapewire entity
2832
SEC CIK
0000318154
Parsed reports
1,877

Last 12 months

Inside the activity.

0 purchase rows · 14 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202500
Jan 202600
Feb 202603
Mar 202600
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202606
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 24, 2012 Filed Oct 25, 2012 22:32 UTC SaleCommon Stock 235,495 $88.06 $20,738,349.09
Disclosure

SEC source: 0001127602-12-029087 · form4.xml · nonDerivative · entry 5

SHARER KEVIN W · CIK 0001185618 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Living Trust

Disclosed balance after: 32,999

F4 · price: The price reported is an average price. The prices ranged from $87.62 to $88.61 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.

Read SEC document
October 24, 2012 Filed Oct 25, 2012 22:32 UTC GiftCommon Stock 195,000 $0.00 $0.00
Disclosure

SEC source: 0001127602-12-029087 · form4.xml · nonDerivative · entry 4

SHARER KEVIN W · CIK 0001185618 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,018

F1 · kind: These shares are being transferred to the reporting person's Living Trust.

F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 9,250 RSUs which fully vest on 4/28/2013; 22,750 RSUs which vest in two equal annual installments of 11,375 each commencing 4/26/2013; 60,000 RSUs which vest in two equal installments of 19,800 each on 4/25/2013 and 4/25/2014 and one installment of 20,400 on 4/25/2015; and 8,933 RSUs which vest in three installments of 2,947, 2,948 and 3,038 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.

F3 · balance_after: These shares include 85 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Read SEC document
October 24, 2012 Filed Oct 25, 2012 22:32 UTC GiftCommon Stock 195,000 $0.00 $0.00
Disclosure

SEC source: 0001127602-12-029087 · form4.xml · nonDerivative · entry 3

SHARER KEVIN W · CIK 0001185618 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Living Trust

Disclosed balance after: 268,494

F1 · kind: These shares are being transferred to the reporting person's Living Trust.

Read SEC document
October 24, 2012 Filed Oct 25, 2012 22:32 UTC Exercise / conversionCommon Stock 193,609 $71.88 $13,916,614.92
Disclosure

SEC source: 0001127602-12-029087 · form4.xml · nonDerivative · entry 2

SHARER KEVIN W · CIK 0001185618 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 296,018

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 24, 2012 Filed Oct 25, 2012 22:32 UTC Exercise / conversionCommon Stock 1,391 $71.88 $99,985.08
Disclosure

SEC source: 0001127602-12-029087 · form4.xml · nonDerivative · entry 1

SHARER KEVIN W · CIK 0001185618 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,409

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 11, 2012 Filed Sep 12, 2012 21:24 UTC Exercise / conversionNqso (Right to Buy) · Derivative 79,625 $0.00 Strike: $58.43 $0.00
Disclosure

SEC source: 0001127602-12-026238 · form4.xml · derivative · entry 12

SHARER KEVIN W · CIK 0001185618 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 159,250

Underlying: Common Stock · 79,625 shares

Expires 2020-04-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 11, 2012 Filed Sep 12, 2012 21:24 UTC Exercise / conversionNqso (Right to Buy) · Derivative 193,402 $0.00 Strike: $62.55 $0.00
Disclosure

SEC source: 0001127602-12-026238 · form4.xml · derivative · entry 11

SHARER KEVIN W · CIK 0001185618 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 193,402 shares

Expires 2014-04-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 11, 2012 Filed Sep 12, 2012 21:24 UTC Exercise / conversionIso (Right to Buy) · Derivative 1,598 $0.00 Strike: $62.55 $0.00
Disclosure

SEC source: 0001127602-12-026238 · form4.xml · derivative · entry 10

SHARER KEVIN W · CIK 0001185618 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,598 shares

Expires 2014-04-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 11, 2012 Filed Sep 12, 2012 21:24 UTC SaleCommon Stock 24,415 $83.97 $2,050,042.10
Disclosure

SEC source: 0001127602-12-026238 · form4.xml · nonDerivative · entry 8

SHARER KEVIN W · CIK 0001185618 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Living Trust

Disclosed balance after: 73,494

F5 · price: The price reported is an average price. The prices ranged from $83.795 to $84.16 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.

Read SEC document
September 11, 2012 Filed Sep 12, 2012 21:24 UTC SaleCommon Stock 50,585 $83.96 $4,247,313.88
Disclosure

SEC source: 0001127602-12-026238 · form4.xml · nonDerivative · entry 7

SHARER KEVIN W · CIK 0001185618 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Living Trust

Disclosed balance after: 97,909

F5 · price: The price reported is an average price. The prices ranged from $83.795 to $84.16 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.

Read SEC document
September 11, 2012 Filed Sep 12, 2012 21:24 UTC SaleCommon Stock 274,625 $83.96 $23,058,009.33
Disclosure

SEC source: 0001127602-12-026238 · form4.xml · nonDerivative · entry 6

SHARER KEVIN W · CIK 0001185618 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Living Trust

Disclosed balance after: 148,494

F4 · price: The price reported is an average price. The prices ranged from $83.79 to $84.12 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.

Read SEC document
September 11, 2012 Filed Sep 12, 2012 21:24 UTC GiftCommon Stock 274,625 $0.00 $0.00
Disclosure

SEC source: 0001127602-12-026238 · form4.xml · nonDerivative · entry 5

SHARER KEVIN W · CIK 0001185618 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,018

F1 · kind: These shares are being transferred to the reporting person's Living Trust.

F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 9,250 RSUs which fully vest on 4/28/2013; 22,750 RSUs which vest in two equal annual installments of 11,375 each commencing 4/26/2013; 60,000 RSUs which vest in two equal installments of 19,800 each on 4/25/2013 and 4/25/2014 and one installment of 20,400 on 4/25/2015; and 8,933 RSUs which vest in three installments of 2,947, 2,948 and 3,038 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.

F3 · balance_after: These shares include 85 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Read SEC document
September 11, 2012 Filed Sep 12, 2012 21:24 UTC GiftCommon Stock 274,625 $0.00 $0.00
Disclosure

SEC source: 0001127602-12-026238 · form4.xml · nonDerivative · entry 4

SHARER KEVIN W · CIK 0001185618 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Living Trust

Disclosed balance after: 423,119

F1 · kind: These shares are being transferred to the reporting person's Living Trust.

Read SEC document
September 11, 2012 Filed Sep 12, 2012 21:24 UTC Exercise / conversionCommon Stock 79,625 $58.43 $4,652,488.75
Disclosure

SEC source: 0001127602-12-026238 · form4.xml · nonDerivative · entry 3

SHARER KEVIN W · CIK 0001185618 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 375,643

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 11, 2012 Filed Sep 12, 2012 21:24 UTC Exercise / conversionCommon Stock 193,402 $62.55 $12,097,295.10
Disclosure

SEC source: 0001127602-12-026238 · form4.xml · nonDerivative · entry 2

SHARER KEVIN W · CIK 0001185618 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 296,018

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 11, 2012 Filed Sep 12, 2012 21:24 UTC Exercise / conversionCommon Stock 1,598 $62.55 $99,954.90
Disclosure

SEC source: 0001127602-12-026238 · form4.xml · nonDerivative · entry 1

SHARER KEVIN W · CIK 0001185618 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,616

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 30, 2012 Filed Aug 31, 2012 22:00 UTC Exercise / conversionNqso (Right to Buy) · Derivative 5,000 $0.00 Strike: $74.89 $0.00
Disclosure

SEC source: 0001127602-12-025539 · form4.xml · derivative · entry 3

SCHAEFFER LEONARD D · CIK 0001016369 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2013-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 30, 2012 Filed Aug 31, 2012 22:00 UTC SaleCommon Stock 5,000 $83.25 $416,253.50
Disclosure

SEC source: 0001127602-12-025539 · form4.xml · nonDerivative · entry 2

SCHAEFFER LEONARD D · CIK 0001016369 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,316

F1 · price: The price reported is an average price. The prices ranged from $83.23 to $83.26 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer.

F2 · balance_after: These shares include 61 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's unvested, and vested but deferred, Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

Read SEC document
August 30, 2012 Filed Aug 31, 2012 22:00 UTC Exercise / conversionCommon Stock 5,000 $74.89 $374,450.00
Disclosure

SEC source: 0001127602-12-025539 · form4.xml · nonDerivative · entry 1

SCHAEFFER LEONARD D · CIK 0001016369 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,316

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 24, 2012 Filed Aug 27, 2012 22:53 UTC Exercise / conversionNqso (Right to Buy) · Derivative 5,000 $0.00 Strike: $74.89 $0.00
Disclosure

SEC source: 0001127602-12-025191 · form4.xml · derivative · entry 3

PELHAM JUDITH C · CIK 0001185287 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2013-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 24, 2012 Filed Aug 27, 2012 22:53 UTC SaleCommon Stock 5,000 $84.37 $421,832.50
Disclosure

SEC source: 0001127602-12-025191 · form4.xml · nonDerivative · entry 2

PELHAM JUDITH C · CIK 0001185287 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,304

F1 · price: The price reported is an average price. The prices ranged from $84.3501 to $84.3801 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.

Read SEC document
August 24, 2012 Filed Aug 27, 2012 22:53 UTC Exercise / conversionCommon Stock 5,000 $74.89 $374,450.00
Disclosure

SEC source: 0001127602-12-025191 · form4.xml · nonDerivative · entry 1

PELHAM JUDITH C · CIK 0001185287 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,304

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 09, 2012 Filed Aug 13, 2012 22:56 UTC SaleCommon Stock 4,500 $81.93 $368,692.20
Disclosure

SEC source: 0001127602-12-024328 · form4.xml · nonDerivative · entry 1

REASON J PAUL · CIK 0001184127 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,591

F1 · price: The price reported is an average price. The prices ranged from $81.931 to $81.932 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer.

F2 · balance_after: These shares include 124 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's unvested, and vested but deferred, Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

Read SEC document
August 06, 2012 Filed Aug 8, 2012 22:14 UTC Exercise / conversionNqso (Right to Buy) · Derivative 5,000 $0.00 Strike: $54.69 $0.00
Disclosure

SEC source: 0001127602-12-024125 · form4.xml · derivative · entry 15

REASON J PAUL · CIK 0001184127 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2021-04-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 06, 2012 Filed Aug 8, 2012 22:14 UTC Exercise / conversionNqso (Right to Buy) · Derivative 5,000 $0.00 Strike: $58.43 $0.00
Disclosure

SEC source: 0001127602-12-024125 · form4.xml · derivative · entry 14

REASON J PAUL · CIK 0001184127 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2020-04-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 06, 2012 Filed Aug 8, 2012 22:14 UTC Exercise / conversionNqso (Right to Buy) · Derivative 5,000 $0.00 Strike: $50.44 $0.00
Disclosure

SEC source: 0001127602-12-024125 · form4.xml · derivative · entry 13

REASON J PAUL · CIK 0001184127 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2016-04-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 06, 2012 Filed Aug 8, 2012 22:14 UTC Exercise / conversionNqso (Right to Buy) · Derivative 5,000 $0.00 Strike: $42.13 $0.00
Disclosure

SEC source: 0001127602-12-024125 · form4.xml · derivative · entry 12

REASON J PAUL · CIK 0001184127 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2015-04-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 06, 2012 Filed Aug 8, 2012 22:14 UTC Exercise / conversionNqso (Right to Buy) · Derivative 5,000 $0.00 Strike: $62.55 $0.00
Disclosure

SEC source: 0001127602-12-024125 · form4.xml · derivative · entry 11

REASON J PAUL · CIK 0001184127 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2014-04-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 06, 2012 Filed Aug 8, 2012 22:14 UTC Tax withholdingCommon Stock 3,327 $82.21 $273,512.67
Disclosure

SEC source: 0001127602-12-024125 · form4.xml · nonDerivative · entry 10

REASON J PAUL · CIK 0001184127 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,091

F1 · balance_after: These shares include 124 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's unvested, and vested but deferred, Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

Read SEC document
August 06, 2012 Filed Aug 8, 2012 22:14 UTC Tax withholdingCommon Stock 3,554 $82.21 $292,174.34
Disclosure

SEC source: 0001127602-12-024125 · form4.xml · nonDerivative · entry 9

REASON J PAUL · CIK 0001184127 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,418

Read SEC document
August 06, 2012 Filed Aug 8, 2012 22:14 UTC Tax withholdingCommon Stock 3,068 $82.21 $252,220.28
Disclosure

SEC source: 0001127602-12-024125 · form4.xml · nonDerivative · entry 8

REASON J PAUL · CIK 0001184127 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,972

Read SEC document
August 06, 2012 Filed Aug 8, 2012 22:14 UTC Tax withholdingCommon Stock 2,563 $82.21 $210,704.23
Disclosure

SEC source: 0001127602-12-024125 · form4.xml · nonDerivative · entry 7

REASON J PAUL · CIK 0001184127 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,040

Read SEC document
August 06, 2012 Filed Aug 8, 2012 22:14 UTC Tax withholdingCommon Stock 3,805 $82.21 $312,809.05
Disclosure

SEC source: 0001127602-12-024125 · form4.xml · nonDerivative · entry 6

REASON J PAUL · CIK 0001184127 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,603

Read SEC document
August 06, 2012 Filed Aug 8, 2012 22:14 UTC Exercise / conversionCommon Stock 5,000 $54.69 $273,450.00
Disclosure

SEC source: 0001127602-12-024125 · form4.xml · nonDerivative · entry 5

REASON J PAUL · CIK 0001184127 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,408

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 06, 2012 Filed Aug 8, 2012 22:14 UTC Exercise / conversionCommon Stock 5,000 $58.43 $292,150.00
Disclosure

SEC source: 0001127602-12-024125 · form4.xml · nonDerivative · entry 4

REASON J PAUL · CIK 0001184127 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,408

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 06, 2012 Filed Aug 8, 2012 22:14 UTC Exercise / conversionCommon Stock 5,000 $50.44 $252,200.00
Disclosure

SEC source: 0001127602-12-024125 · form4.xml · nonDerivative · entry 3

REASON J PAUL · CIK 0001184127 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,408

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 06, 2012 Filed Aug 8, 2012 22:14 UTC Exercise / conversionCommon Stock 5,000 $42.13 $210,650.00
Disclosure

SEC source: 0001127602-12-024125 · form4.xml · nonDerivative · entry 2

REASON J PAUL · CIK 0001184127 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,408

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 06, 2012 Filed Aug 8, 2012 22:14 UTC Exercise / conversionCommon Stock 5,000 $62.55 $312,750.00
Disclosure

SEC source: 0001127602-12-024125 · form4.xml · nonDerivative · entry 1

REASON J PAUL · CIK 0001184127 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,408

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 01, 2012 Filed Aug 1, 2012 23:50 UTC
RICHO ANNASVP & CCO
Exercise / conversionNqso (Right to Buy) · Derivative 5,125 $0.00 Strike: $62.63 $0.00
Disclosure

SEC source: 0001127602-12-023459 · form4.xml · derivative · entry 6

RICHO ANNA · CIK 0001199306 · SVP & CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,125 shares

Expires 2015-07-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 01, 2012 Filed Aug 1, 2012 23:50 UTC
RICHO ANNASVP & CCO
SaleCommon Stock 5,125 $83.06 $425,697.88
Disclosure

SEC source: 0001127602-12-023459 · form4.xml · nonDerivative · entry 4

RICHO ANNA · CIK 0001199306 · SVP & CCO

10b5-1 filing: Not disclosed

Ownership: Indirect · The Nicholas A. Moore and Anna S. Richo Family Trust

Disclosed balance after: 10,256

F5 · price: The price reported is an average price. The prices ranged from $83.04 to $83.11 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.

Read SEC document
August 01, 2012 Filed Aug 1, 2012 23:50 UTC
RICHO ANNASVP & CCO
GiftCommon Stock 5,125 $0.00 $0.00
Disclosure

SEC source: 0001127602-12-023459 · form4.xml · nonDerivative · entry 3

RICHO ANNA · CIK 0001199306 · SVP & CCO

10b5-1 filing: Not disclosed

Ownership: Indirect · The Nicholas A. Moore and Anna S. Richo Family Trust

Disclosed balance after: 15,381

F1 · kind: These shares are being transferred to the reporting person's Family Trust.

Read SEC document
August 01, 2012 Filed Aug 1, 2012 23:50 UTC
RICHO ANNASVP & CCO
GiftCommon Stock 5,125 $0.00 $0.00
Disclosure

SEC source: 0001127602-12-023459 · form4.xml · nonDerivative · entry 2

RICHO ANNA · CIK 0001199306 · SVP & CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,867

F1 · kind: These shares are being transferred to the reporting person's Family Trust.

F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,425 RSUs which fully vest on 4/28/2013; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 20,000 RSUs which fully vest on 10/28/2013; 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015; and 3,350 RSUs which vest in three installments of 1,105, 1,106 and 1,139 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F3 · balance_after: These shares include 1,675 shares of common stock acquired under the Company's Employee Stock Purchase Plan.

F4 · balance_after: These shares include 17 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Read SEC document
August 01, 2012 Filed Aug 1, 2012 23:50 UTC
RICHO ANNASVP & CCO
Exercise / conversionCommon Stock 5,125 $62.63 $320,978.75
Disclosure

SEC source: 0001127602-12-023459 · form4.xml · nonDerivative · entry 1

RICHO ANNA · CIK 0001199306 · SVP & CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,992

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2012 Filed Aug 1, 2012 23:39 UTC
Dittrich Thomas J.W.VP, Finance & CAO
Exercise / conversionNqso (Right to Buy) · Derivative 2,150 $0.00 Strike: $58.43 $0.00
Disclosure

SEC source: 0001127602-12-023455 · form4.xml · derivative · entry 9

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,300

Underlying: Common Stock · 2,150 shares

Expires 2020-04-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2012 Filed Aug 1, 2012 23:39 UTC
Dittrich Thomas J.W.VP, Finance & CAO
Exercise / conversionNqso (Right to Buy) · Derivative 2,000 $0.00 Strike: $50.44 $0.00
Disclosure

SEC source: 0001127602-12-023455 · form4.xml · derivative · entry 8

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Underlying: Common Stock · 2,000 shares

Expires 2016-04-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2012 Filed Aug 1, 2012 23:39 UTC
Dittrich Thomas J.W.VP, Finance & CAO
Exercise / conversionNqso (Right to Buy) · Derivative 3,000 $0.00 Strike: $42.13 $0.00
Disclosure

SEC source: 0001127602-12-023455 · form4.xml · derivative · entry 7

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,000 shares

Expires 2015-04-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2012 Filed Aug 1, 2012 23:39 UTC
Dittrich Thomas J.W.VP, Finance & CAO
Exercise / conversionNqso (Right to Buy) · Derivative 25,000 $0.00 Strike: $69.83 $0.00
Disclosure

SEC source: 0001127602-12-023455 · form4.xml · derivative · entry 6

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2013-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2012 Filed Aug 1, 2012 23:39 UTC
Dittrich Thomas J.W.VP, Finance & CAO
SaleCommon Stock 32,150 $82.69 $2,658,387.05
Disclosure

SEC source: 0001127602-12-023455 · form4.xml · nonDerivative · entry 5

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,721

F1 · price: The price reported is an average price. The prices ranged from $82.67 to $82.75 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer.

F2 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 286 RSUs which fully vest on 4/28/2013; 615 RSUs which vest in annual installments of 307 on 4/26/2013 and 308 on 4/26/2014; 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively; and 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F3 · balance_after: These shares include 7 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Read SEC document
July 31, 2012 Filed Aug 1, 2012 23:39 UTC
Dittrich Thomas J.W.VP, Finance & CAO
Exercise / conversionCommon Stock 2,150 $58.43 $125,624.50
Disclosure

SEC source: 0001127602-12-023455 · form4.xml · nonDerivative · entry 4

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,871

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2012 Filed Aug 1, 2012 23:39 UTC
Dittrich Thomas J.W.VP, Finance & CAO
Exercise / conversionCommon Stock 2,000 $50.44 $100,880.00
Disclosure

SEC source: 0001127602-12-023455 · form4.xml · nonDerivative · entry 3

Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,721

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.